XML 27 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Private Placement [Member]
Common Stock [Member]
Public Stock Offering [Member]
Common Stock [Member]
Outside Directors [Member]
Common Stock [Member]
Employee Directors [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Private Placement [Member]
Additional Paid-in Capital [Member]
Public Stock Offering [Member]
Additional Paid-in Capital [Member]
Outside Directors [Member]
Additional Paid-in Capital [Member]
Employee Directors [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Private Placement [Member]
Retained Earnings [Member]
Public Stock Offering [Member]
Retained Earnings [Member]
Outside Directors [Member]
Retained Earnings [Member]
Employee Directors [Member]
Retained Earnings [Member]
Private Placement [Member]
Public Stock Offering [Member]
Outside Directors [Member]
Employee Directors [Member]
Total
Balance (in shares) at Dec. 31, 2021         96,774,000                              
Balance at Dec. 31, 2021         $ 10         $ 617,489         $ (64,436)         $ 553,063
Dividends declared         0         0         (10,623)         (10,623)
Dividend equivalents declared on outstanding stock options         $ 0         0         (1,055)         (1,055)
Stock issued for acquisitions (in shares)         10,854,000                              
Stock issued for acquisitions         $ 1         264,981         0         264,982
Stock issued (in shares) 3,933,000                                      
Stock issued $ 0         $ 85,000         $ 0         $ 85,000        
Stock issuance costs         $ 0         (339)         0         (339)
Exercise of warrants (in shares)         971,000                              
Exercise of warrants         $ 0         7,805         0         $ 7,805
Shares issued upon options being exercised (in shares)         12,000                             12,000
Shares issued upon options being exercised         $ 0         120         0         $ 120
Restricted shares issued (in shares)     21,000 600,000                                
Restricted shares issued     $ 0 $ 0       $ 0 $ 0       $ 0 $ 0       $ 0 $ 0  
Compensation costs included in net loss         0         33,840         0         33,840
Net loss         $ 0         0         236,854         236,854
Balance (in shares) at Dec. 31, 2022         113,165,000                              
Balance at Dec. 31, 2022         $ 11         1,008,896         160,740         1,169,647
Dividends declared         0         0         (12,076)         (12,076)
Dividend equivalents declared on outstanding stock options         0         0         (1,246)         (1,246)
Stock issued (in shares)   14,835,000                                    
Stock issued   $ 2         $ 155,766         $ 0         $ 155,768      
Stock issuance costs         $ 0         (5,371)         0         (5,371)
Exercise of warrants (in shares)         350,000                              
Exercise of warrants         $ 0         4,028         0         $ 4,028
Shares issued upon options being exercised (in shares)         12,000                             11,834
Shares issued upon options being exercised         $ 0         148         0         $ 148
Restricted shares issued (in shares)     59,000                                  
Restricted shares issued     $ 0         0         0         0    
Compensation costs included in net loss         0         25,957         0         25,957
Net loss         $ 0         0         215,866         215,866
Balance (in shares) at Dec. 31, 2023         128,421,000                              
Balance at Dec. 31, 2023         $ 13         1,189,424         363,284         1,552,721
Dividends declared         0         0         (20,395)         (20,395)
Dividend equivalents declared on outstanding stock options         $ 0         0         (2,124)         (2,124)
Exercise of warrants (in shares)         0                              
Exercise of warrants         $ 0         1         0         1
Restricted shares issued (in shares)     54,000                                  
Restricted shares issued     $ 0         $ 0         $ 0         $ 0    
Compensation costs included in net loss         0         12,701         0         12,701
Net loss         $ 0         0         95,069         95,069
Repurchased shares under buyback program (in shares)         (2,408,000)                              
Repurchased shares under buyback program         $ 0         (35,517)         0         (35,517)
Balance (in shares) at Dec. 31, 2024         126,067,000                              
Balance at Dec. 31, 2024         $ 13         $ 1,166,609         $ 435,834         $ 1,602,456